BIT 23.1% 1.0¢ biotron limited

Ann: Agreement with C14 Consulting Group, page-3

  1. 2,937 Posts.
    lightbulb Created with Sketch. 309
    Earlier, Ms. Molsbergen served as Vice President of Business Development for BioWa, Inc., for which she played a key role in establishing and building the novel antibody engineering platform company as a subsidiary of the Japanese company, Kyowa Hakko Kogyo (KHK). In three years of business activity, she successfully negotiated more than 15 deals valued at over $2.5 billion in future milestone payment and royalties with leading antibody and biopharma companies. She participated with KHK to identify new investment opportunities, and strategic planning for internal product pipeline development. The efforts led to the creation of market value of BioWa to reach over $1 billion in three years. Ms. Molsbergen received two President’s awards for her achievements. She has been featured in Nikkei Magazine for her business deal achievements with and on behalf of Japanese companies (May 2007 and June 2012).
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
-0.003(23.1%)
Mkt cap ! $9.023M
Open High Low Value Volume
1.2¢ 1.2¢ 0.9¢ $144.6K 13.96M

Buyers (Bids)

No. Vol. Price($)
7 4548103 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2386271 9
View Market Depth
Last trade - 16.10pm 07/02/2025 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.